Liquid Biopsy Market, By Cancer Type (Lung, Breast, Colorectal, Prostate), By Circulating Biomarkers (Circulating Tumor Cells, Circulating Tumor DNA, Cell-Free DNA), By Product (Instruments, Assay Kits), By End User (Reference Laboratory), By Region (North America, Western Europe, Eastern Europe, Asia Pacific, Middle East, Rest of the World) – Market Size & Forecasting (2016-2028)

The Liquid Biopsy Market report highlights market opportunities and competitive scenarios for a liquid biopsy on a regional and global basis. Market size estimation and forecasts have been provided based on a unique research design customized to the dynamics of the liquid biopsy market. The liquid biopsy market has been segmented by cancer type (lung, breast, colorectal, prostate), by circulating biomarkers (circulating tumor cells, circulating tumor DNA, cell-free DNA), by product (instruments, assay kits), by end-user (reference laboratory). Historic back-drop for liquid biopsy market has been analyzed according to organic and inorganic developments to provide precise market size estimations. Also, key factors impacting the growth of the liquid biopsy market have been identified with potential gravity. Major regions covered in the study include North America, Western Europe, Eastern Europe, Asia Pacific, Middle East, and Rest of the World.

Market Segmentation:

By Cancer Type:

  • Lung
  • Breast
  • Colorectal
  • Prostate

By Circulating Biomarkers:

  • Circulating Tumor Cells
  • Circulating Tumor DNA
  • Cell-Free DNA

By Product:

  • Instruments
  • Assay Kits

By End User:

  • Reference Laboratory

By Region:

  • North America
    • North America, by Country
      • US
      • Canada
      • Mexico
    • North America, by Cancer Type
    • North America, by Circulating Biomarkers
    • North America, by Product
    • North America, by End User
  • Western Europe
    • Western Europe, by Country
      • Germany
      • UK
      • France
      • Italy
      • Spain
      • The Netherlands
      • Rest of Western Europe
    • Western Europe, by Cancer Type
    • Western Europe, by Circulating Biomarkers
    • Western Europe, by Product
    • Western Europe, by End User
  • Asia Pacific
    • Asia Pacific, by Country
      • China
      • India
      • Japan
      • South Korea
      • Australia
      • Indonesia
      • Rest of Asia Pacific
    • Asia Pacific, by Cancer Type
    • Asia Pacific, by Circulating Biomarkers
    • Asia Pacific, by Product
    • Asia Pacific, by End User
  • Eastern Europe
    • Eastern Europe, by Country
      • Russia
      • Turkey
      • Rest of Eastern Europe
    • Eastern Europe, by Cancer Type
    • Eastern Europe, by Circulating Biomarkers
    • Eastern Europe, by Product
    • Eastern Europe, by End User
  • Middle East
    • Middle East, by Country
      • UAE
      • Saudi Arabia
      • Qatar
      • Iran
      • Rest of Middle East
    • Middle East, by Cancer Type
    • Middle East, by Circulating Biomarkers
    • Middle East, by Product
    • Middle East, by End User
  • Rest of the World
    • Rest of the World, by Country
      • South America
      • Africa
    • Rest of the World, by Cancer Type
    • Rest of the World, by Circulating Biomarkers
    • Rest of the World, by Product
    • Rest of the World, by End User

Major Companies:

Roche Diagnostics, Bio-Rad Laboratories Inc., Myriad Genetics, Inc., Menarini Silicon Biosystems, Genomic Health, Inc., Thermo Fisher Scientific Inc, Illumina, Inc.

Years Covered in the Study:

Historic Year: 2016-2017

Base Year: 2018

Estimated Year: 2019

Forecast Year: 2028

Objectives of this report:

  • To estimate the market size for liquid biopsy market on a regional and global basis.
  • To identify major segments in liquid biopsy market and evaluate their market shares and demand.
  • To provide a competitive scenario for the liquid biopsy market with major developments observed by key companies in the historic years.
  • To evaluate key factors governing the dynamics of liquid biopsy market with their potential gravity during the forecast period.

Reasons to Buy This Report:

  • Provides niche insights for a decision about every possible segment helping in the strategic decision-making process.
  • Market size estimation of the liquid biopsy market on a regional and global basis.
  • A unique research design for market size estimation and forecast.
  • Identification of major companies operating in the market with related developments
  • Exhaustive scope to cover all the possible segments helping every stakeholder in the liquid biopsy market.

Customization:

This study is customized to meet your specific requirements:

  • By Segment
  • By Sub-segment
  • By Region/Country
  • Product Specific Competitive Analysis

For more information, contact: sales@quincemarketinsights.com